Evolent Other Non Cash Items vs Begin Period Cash Flow Analysis

EVH Stock  USD 11.43  0.36  3.25%   
Evolent Health financial indicator trend analysis is much more than just examining Evolent Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evolent Health is a good investment. Please check the relationship between Evolent Health Other Non Cash Items and its Begin Period Cash Flow accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Other Non Cash Items vs Begin Period Cash Flow

Other Non Cash Items vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evolent Health Other Non Cash Items account and Begin Period Cash Flow. At this time, the significance of the direction appears to have very week relationship.
The correlation between Evolent Health's Other Non Cash Items and Begin Period Cash Flow is 0.2. Overlapping area represents the amount of variation of Other Non Cash Items that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Evolent Health, assuming nothing else is changed. The correlation between historical values of Evolent Health's Other Non Cash Items and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Non Cash Items of Evolent Health are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Other Non Cash Items i.e., Evolent Health's Other Non Cash Items and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.2
Relationship DirectionPositive 
Relationship StrengthVery Weak

Other Non Cash Items

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from Evolent Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evolent Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.As of now, Evolent Health's Issuance Of Capital Stock is increasing as compared to previous years. The Evolent Health's current Sales General And Administrative To Revenue is estimated to increase to 0.55, while Selling General Administrative is projected to decrease to under 236.7 M.
 2021 2022 2023 2024 (projected)
Total Revenue908.0M1.4B2.0B2.1B
Depreciation And Amortization60.0M90.3M123.4M129.6M

Evolent Health fundamental ratios Correlations

0.870.890.860.680.76-0.640.610.70.990.870.480.650.870.850.540.780.920.850.980.25-0.480.240.9-0.210.73
0.870.990.530.630.85-0.890.360.560.860.910.320.520.970.720.290.830.980.750.920.35-0.780.170.95-0.340.8
0.890.990.580.690.83-0.90.410.630.870.910.370.580.950.770.370.840.980.80.920.36-0.740.240.93-0.390.83
0.860.530.580.670.44-0.320.740.760.840.60.580.690.520.850.680.610.620.840.740.17-0.050.30.6-0.20.6
0.680.630.690.670.56-0.740.530.710.660.610.690.640.510.840.780.790.650.750.60.47-0.320.170.6-0.740.86
0.760.850.830.440.56-0.770.210.210.80.850.140.120.890.550.290.750.890.50.850.1-0.69-0.120.92-0.170.71
-0.64-0.89-0.9-0.32-0.74-0.77-0.27-0.49-0.62-0.79-0.33-0.44-0.8-0.66-0.31-0.85-0.85-0.66-0.7-0.420.77-0.13-0.80.59-0.87
0.610.360.410.740.530.21-0.270.650.540.390.530.610.320.630.560.540.440.710.490.05-0.010.310.42-0.130.49
0.70.560.630.760.710.21-0.490.650.620.50.780.940.440.810.580.60.560.90.570.61-0.140.40.46-0.540.6
0.990.860.870.840.660.8-0.620.540.620.880.410.570.870.820.530.750.920.790.980.19-0.490.20.91-0.180.71
0.870.910.910.60.610.85-0.790.390.50.880.190.470.940.780.250.760.930.720.920.15-0.760.170.91-0.310.81
0.480.320.370.580.690.14-0.330.530.780.410.190.730.180.580.720.490.360.620.350.770.150.010.32-0.460.33
0.650.520.580.690.640.12-0.440.610.940.570.470.730.410.790.530.530.520.820.530.59-0.140.50.42-0.510.52
0.870.970.950.520.510.89-0.80.320.440.870.940.180.410.670.180.790.980.670.950.2-0.770.120.97-0.150.71
0.850.720.770.850.840.55-0.660.630.810.820.780.580.790.670.630.770.770.910.770.35-0.380.290.72-0.480.83
0.540.290.370.680.780.29-0.310.560.580.530.250.720.530.180.630.480.370.530.410.250.190.280.33-0.370.47
0.780.830.840.610.790.75-0.850.540.60.750.760.490.530.790.770.480.850.760.780.3-0.50.150.84-0.380.82
0.920.980.980.620.650.89-0.850.440.560.920.930.360.520.980.770.370.850.770.970.3-0.710.140.99-0.260.78
0.850.750.80.840.750.5-0.660.710.90.790.720.620.820.670.910.530.760.770.780.45-0.360.320.7-0.450.8
0.980.920.920.740.60.85-0.70.490.570.980.920.350.530.950.770.410.780.970.780.2-0.590.180.96-0.140.71
0.250.350.360.170.470.1-0.420.050.610.190.150.770.590.20.350.250.30.30.450.2-0.16-0.170.24-0.60.24
-0.48-0.78-0.74-0.05-0.32-0.690.77-0.01-0.14-0.49-0.760.15-0.14-0.77-0.380.19-0.5-0.71-0.36-0.59-0.160.07-0.690.34-0.64
0.240.170.240.30.17-0.12-0.130.310.40.20.170.010.50.120.290.280.150.140.320.18-0.170.070.02-0.160.25
0.90.950.930.60.60.92-0.80.420.460.910.910.320.420.970.720.330.840.990.70.960.24-0.690.02-0.150.72
-0.21-0.34-0.39-0.2-0.74-0.170.59-0.13-0.54-0.18-0.31-0.46-0.51-0.15-0.48-0.37-0.38-0.26-0.45-0.14-0.60.34-0.16-0.15-0.66
0.730.80.830.60.860.71-0.870.490.60.710.810.330.520.710.830.470.820.780.80.710.24-0.640.250.72-0.66
Click cells to compare fundamentals

Evolent Health Account Relationship Matchups

Evolent Health fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.5B1.4B1.4B1.8B2.7B2.8B
Other Current Liab129.2M319.9M323.3M356.3M600.5M630.6M
Total Current Liabilities192.8M401.8M445.5M433.4M674.2M708.0M
Total Stockholder Equity922.4M619.6M693.6M859.4M1.1B706.1M
Property Plant And Equipment Net157.3M144.0M131.6M136.9M90.2M84.7M
Net Debt267.8M19.3M14.2M287.9M452.0M474.6M
Retained Earnings(252.0M)(589.2M)(626.8M)(606.2M)(719.2M)(683.2M)
Accounts Payable37.5M32.0M96.1M57.2M48.2M48.9M
Cash101.0M340.5M266.3M188.2M192.8M176.4M
Non Current Assets Total1.3B824.1M895.5M1.3B2.0B2.1B
Non Currrent Assets Other8.3M7.3M13.0M32.3M33.0M34.7M
Other Assets92.0M186.5M52.4M32.3M33.0M60.4M
Cash And Short Term Investments101.0M340.5M266.3M188.2M192.8M196.3M
Net Receivables77.4M124.4M130.6M254.7M446.7M469.1M
Common Stock Shares Outstanding82.4M84.9M86.1M93.7M111.3M70.4M
Liabilities And Stockholders Equity1.5B1.4B1.4B1.8B2.7B2.8B
Other Current Assets200.5M104.6M127.1M35.2M44.1M73.6M
Other Stockholder Equity1.2B1.2B1.3B1.5B1.8B1.9B
Total Liab569.0M750.6M725.8M957.9M1.6B1.7B
Total Current Assets228.8M546.1M524.0M478.1M683.7M354.3M
Intangible Assets308.5M268.1M279.8M442.8M752.0M789.6M
Other Liab13.7M455.2M6.9M55.4M63.8M71.7M
Current Deferred Revenue19.8M14.3M11.9M5.8M6.0M5.7M
Short Term Investments1.8M3.9M75.7M14.5M13.8M25.7M
Non Current Liabilities Total376.2M348.8M280.3M524.4M938.4M985.3M
Inventory78.5M(150.1M)(445.1M)(308.2M)(415.9M)1.05
Property Plant And Equipment Gross157.3M144.0M250.7M287.4M248.7M139.8M
Accumulated Other Comprehensive Income(234K)(278K)(362K)(1.2M)(1.3M)(1.3M)
Short Term Debt6.3M41.3M14.1M14.2M19.5M18.5M
Property Plant Equipment85.2M86.2M81.4M87.9M101.1M60.1M
Net Tangible Assets41.8M(3.2M)(12.4M)(306.1M)(275.5M)(261.8M)
Long Term Debt293.7M263.3M215.7M413.0M597.0M626.9M
Good Will572.1M354.7M426.3M722.8M1.1B707.6M
Common Stock Total Equity846K859K908K1.0M1.2M791.4K
Deferred Long Term Liab1.9M728K1.4M4.7M4.3M4.1M
Long Term Investments139.4M17.4M5.5M4.5M4.9M4.7M
Common Stock846K859K908K1.0M1.2M839.2K
Retained Earnings Total Equity(252.0M)(589.2M)(626.8M)(606.2M)(545.5M)(518.3M)

Currently Active Assets on Macroaxis

When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
21.554
Quarterly Revenue Growth
0.216
Return On Assets
0.0073
Return On Equity
(0.06)
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.